5600 |
MITOGEN-ACTIVATED PROTEIN KINASE 11 |
MAPK11 |
P38B |
P38BETA2 |
PRKM11 |
SAPK2 |
SAPK2B |
p38-2 |
p38Beta |
602898 |
6873 |
ENSG00000185386 |
OTTHUMG00000150226 |
MK11_HUMAN |
Q15759 |
PA30618 |
MAP kinase p38 beta |
MAPK 11 |
MAP kinase 11 |
Stress-activated protein kinase 2b |
Mitogen-activated protein kinase p38 beta |
MITOGEN-ACTIVATED PROTEIN KINASE 11 (EC 2.7.1.37) (MITOGEN-ACTIVATED PROTEIN KINASE P38 BETA) (MAP KINASE P38 BETA) (P38B) (P38-2) (STRESS- ACTIVATED PROTEIN KINASE-2). [SOURCE:UNIPROT/SWISSPROT;ACC:Q15759] |
p38 beta |
T55729 |
Uniprot Evidence | 1: Evidence at protein level |
Uniprot Status | Swiss-Prot |
Interpro Name | Serine/threonine- / dual-specificity protein kinase, catalytic domain |
Interpro Acc | IPR002290 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Type | Domain |
Interpro Short Name | Ser/Thr_dual-sp_kinase_dom |
Human Readable Name | KINASE |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.24 |
Gene Biotype | PROTEIN_CODING |
KINASE |
SERINE THREONINE KINASE |
DRUGGABLE GENOME |
TRANSCRIPTION FACTOR |
inhibitor (inhibitory) |
Mechanism of Interaction | MAP kinase p38 beta inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | MAP kinase p38 beta inhibitor |
Direct Interaction | yes |
n/a |
Trial Name | BMS-582949 |
Novel drug target | Novel Target |
n/a |
Trial Name | ARRY-797 |
Novel drug target | Novel Target |
inhibitor (inhibitory) |
inhibitor (inhibitory) |
Trial Name | PH-797804 |
Novel drug target | Novel Target |
n/a |
Trial Name | CPSI-2364 |
Novel drug target | Novel Target |
n/a |
Trial Name | pirfenidone,Esbriet , Deskar, Pirespa |
Novel drug target | Novel Target |
inhibitor (inhibitory) |
Trial Name | ARRY-614 |
Novel drug target | Novel Target |
inhibitor (inhibitory) |
Trial Name | VX-702 |
Novel drug target | Novel Target |
inhibitor (inhibitory) |
Mechanism of Interaction | MAP kinase p38 beta inhibitor |
Direct Interaction | yes |
MAPK11 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
MAPK11 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.24 |
MITOGEN-ACTIVATED PROTEIN KINASE 11 (EC 2.7.1.37) (MITOGEN-ACTIVATED PROTEIN KINASE P38 BETA) (MAP KINASE P38 BETA) (P38B) (P38-2) (STRESS- ACTIVATED PROTEIN KINASE-2). [SOURCE:UNIPROT/SWISSPROT;ACC:Q15759] | Description |
ENSG00000185386 | Ensembl Gene Id |
MAPK11 | Display Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
Q15759 | Uniprot Accession |
5600 | Entrez Gene Id |
MAPK11 | Uniprot Gene Name |
Uniprot Evidence | 1: Evidence at protein level |
Uniprot Status | Swiss-Prot |
Interpro Name | Serine/threonine- / dual-specificity protein kinase, catalytic domain |
KINASE, DRUGGABLE GENOME |
PA30618 | PharmGKB ID |
ENSG00000185386 | Gene Symbol |
MAPK11 | Ensembl Id |
DRUGGABLE GENOME |
SAPK2 | GENE_SYMBOL |
SAPK2B | GENE_SYMBOL |
MAPK11 | GENE_SYMBOL |
PRKM11 | GO Gene Synonym |
SAPK2 | GO Gene Synonym |
SAPK2B | GO Gene Synonym |
SERINE THREONINE KINASE |
5600 | Gene ID |
P38B | dGene Synonym |
P38BETA2 | dGene Synonym |
KINASE, SERINE THREONINE KINASE |
p38 beta | TTD Gene Abbreviation |
T55729 | TTD Target ID |
Mitogen-activated protein kinase 11 | Gene Name |
Q15759 | UniProt ID |
KINASE, TRANSCRIPTION FACTOR |